Related Experiment Video
Updated: Jul 20, 2026
09:44
Development, Characterization, and Evaluation of CAGE-based Ionic Liquid Systems for Transdermal Delivery
Published on: September 26, 2025
Cutaneous reactions to transdermal therapeutic systems
Andrea L Musel1, Erin M Warshaw
1University of Minnesota School of Medicine, Minneapolis, MN, USA.
Dermatitis : Contact, Atopic, Occupational, Drug
|September 8, 2006
Summary
Transdermal therapeutic systems are common, but skin reactions can reduce patient adherence. This review details these side effects and lists known allergens for transdermal drug delivery systems.
Area of Science:
- Dermatology
- Pharmacology
- Drug Delivery Systems
Background:
- Transdermal therapeutic systems (TTS) have seen widespread adoption over the last 20 years.
- Cutaneous side effects associated with TTS are a significant clinical issue.
- These adverse skin reactions frequently lead to decreased patient compliance with prescribed treatments.
Purpose of the Study:
- To comprehensively review the range of cutaneous reactions caused by transdermal therapeutic systems.
- To provide an updated compilation of identified allergens implicated in TTS-induced dermatoses.
- To inform healthcare professionals about potential skin adverse events and allergens related to TTS.
Main Methods:
- Systematic literature review of studies on transdermal therapeutic systems and associated cutaneous reactions.
- Analysis of reported adverse events, including contact dermatitis, irritant reactions, and allergic sensitization.
- Compilation and categorization of known allergens identified through patch testing and clinical case reports.
Main Results:
- A wide spectrum of cutaneous side effects has been documented with TTS use.
- Common reactions include irritant contact dermatitis and allergic contact dermatitis.
- Specific allergens within TTS formulations have been identified, contributing to sensitization.
Conclusions:
- Understanding the spectrum of cutaneous reactions is crucial for managing TTS therapy.
- Identification of allergens aids in preventing and treating TTS-induced skin reactions.
- Improved management strategies can enhance patient compliance and therapeutic outcomes with transdermal systems.
Related Concept Videos
01:18Transdermal Drug Delivery Systems
Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...
01:30Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
01:29Hypersensitivity Reactions: Delayed Hypersensitivity Reactions
Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
01:27Allergic Drug Reactions
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
01:19Hypersensitivity Reactions: Immune-Complex Reactions
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...
01:30Hypersensitivities
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...